Tuvusertib in Astrocytoma With ATRX Mutation

NCT07417761 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Astrocytoma

Interventions

DRUG: Tuvusertib

Sponsor

Grupo Español de Investigación en Neurooncología